health
FDA Shuffles Top Drug, Biologics Leaders in Latest Shakeup
The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former commissioner Marty Makary.
TL;DR
- The FDA is changing its top drug and biologics regulators.
- Acting directors Tracy Beth Høeg (CDER) and Katherine Szarama (CBER) are leaving their roles.
- Michael Davis will replace Høeg, and Karim Mikhail will replace Szarama.
- The changes occur shortly after the departure of former commissioner Marty Makary.
- The FDA has experienced significant turnover in leadership positions.
- The Trump administration is also seeking to fill other health vacancies.